Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ImmunOnco Biopharmaceuticals
Shanghai, Shanghai, China
- Ownership
- Private
- Employees
- ~200
- Development stage
- Other
01
Overview
ImmunOnco Biopharmaceuticals is a clinical-stage biotechnology company dedicated to developing next-generation cancer immunotherapies by targeting innate immunity. The company focuses on the CD47/SIRPα axis and other novel checkpoints like CD24 to activate macrophages and other innate immune cells against tumors. Their lead candidate, IMM01, is a SIRPα-Fc fusion protein designed to minimize hemagglutination while maximizing anti-tumor activity. With a robust pipeline of monoclonal and bispecific antibodies, ImmunOnco aims to provide innovative solutions for both hematologic malignancies and solid tumors.
- Therapeutic areas
- HematologyOncology
- Modalities
- Monoclonal antibodyBispecific monoclonal antibodyRecombinant fusion proteinBiologic
- Industry
- Biotech
02
Partnerships
Synermore Biologics
Beyond the preview
Go deeper on ImmunOnco Biopharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ImmunOnco Biopharmaceuticals.